Related to breast cancer, Tanaka et al. revealed that EGCG had reduced rRNA transcription and cell proliferation through the activation of KDM2A in MCF-7 cells, and EGCG helps in KDM2A activation by the activation of both 5’ AMP-activated protein kinase (AMPK) and ROS production. Here, KDM2A is linked to breast carcinoma.